Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Adenocarcinoma × Brachytherapy × Clear all

Phase

Phase 2/3 1 Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Uterine Cervical Neoplasms 1 Deglutition Disorders 1 Adenocarcinoma 1

Interventions

Oxaliplatin 2 Fluorouracil 2 rubitecan 1 nimotuzumab 1 halofantrine 1 gallium 68 PSMA-11 1 camrelizumab 1 apatinib 1 S 1 (combination) 1 Radiotherapy 1 Radiosurgery 1 Radiation 1 Photochemotherapy 1 Nadroparin 1 Heparin, Low-Molecular-Weight 1 Gastrectomy 1 Esophagectomy 1 Docetaxel 1 Cisplatin 1 Chemoradiotherapy 1 Capecitabine 1 CP protocol 1 Brachytherapy 1 Atrasentan 1 Androgen Antagonists 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01786278 2013-02-07

BRASTEGAC

Medical University of Lublin

Phase 2/3 Unknown

Adenocarcinoma, Deglutition Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡